COMMUNIQUÉS West-GlobeNewswire

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, Inc. ("OncoMed") – Result of OncoMed Stockholder Meeting
18/04/2019
LONDON, April 18, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, announces today that stockholders of OncoMed (NASDAQ: OMED [...]
Nicox First Quarter 2019 Business Update and Financial Highlights
18/04/2019
Press Release Nicox First Quarter 2019 Business Update and Financial Highlights ………………………………………………………………………………………………………………………….. Total VYZULTA® prescriptions for the first quarter 2019 increased by 18% compared to the [...]
Nicox : Point d’activité et résumé financier du premier trimestre 2019
18/04/2019
Communiqué de presse Nicox : Point d’activité et résumé financier du premier trimestre 2019 ………………………………………………………………………………………………………………………….. • Augmentation de 18% du nombre total de prescriptions de VYZULTA ® pour le [...]
Genfit: GENFIT Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC
18/04/2019
GENFIT Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC FDA grants elafibranor Breakthrough Therapy Designation, based on Phase 2 data, for treatment of PBC (Primary [...]
Genfit : GENFIT annonce l’attribution de la Breakthrough Therapy Designation à elafibranor, par la FDA, pour le traitement de la PBC
18/04/2019
GENFIT annonce l’attribution de la Breakthrough Therapy Designation à elafibranor, par la FDA, pour le traitement de la PBC La FDA attribue à elafibranor la Breakthrough Therapy Designation, sur base des données de [...]
HOOKIPA Pharma Announces Pricing of Initial Public Offering
18/04/2019
NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus [...]
Helix BioPharma Corp. Retains U.S. Legal and Capital Firms to Advise on U.S. Listing
17/04/2019
RICHMOND HILL, Ontario, April 17, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Globus Medical Schedules First Quarter 2019 Earnings Release and Conference Call
17/04/2019
AUDUBON, Pa., April 17, 2019 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2019 after the [...]
St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine
17/04/2019
Licensing partnership for vector between St. Jude and Mustang Bio announced in Summer, 2018 This Phase 1/2 trial in newly diagnosed infants with XSCID continues to enroll at St. Jude, UCSF Benioff Children’s Hospital [...]
Profound Medical to Release First Quarter 2019 Financial Results on May 6 – Conference Call to Follow
17/04/2019
TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Conformis to Host First Quarter 2019 Financial Results Webcast on May 1, 2019
17/04/2019
BILLERICA, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, May 1, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for [...]
Kiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
17/04/2019
HAMILTON, Bermuda, April 17, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]
Kane Biotech Announces Granting of Options
17/04/2019
WINNIPEG, Manitoba, April 17, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Portola Pharmaceuticals to Announce First Quarter 2019 Financial Results on Wednesday, May 8, 2019
17/04/2019
SOUTH SAN FRANCISCO, Calif., April 17, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]
Affimed Provides Regulatory Update on AFM11 Clinical Program
17/04/2019
Heidelberg, Germany, April 17, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced that it has submitted [...]
Aduro Biotech Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting
17/04/2019
BERKELEY, Calif., April 17, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical stage biopharmaceutical company developing therapies in the Stimulator of Interferon Genes (STING) and A Proliferation [...]
Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Transaction
17/04/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, April 17, 2019 ( [...]
More Than 300 Hospice Advocates Converge on Capitol Hill
17/04/2019
Advocates met with 350 House and Senate offices to educate about issues impacting the hospice and palliative care community WASHINGTON, April 17, 2019 (GLOBE NEWSWIRE) -- More than 300 hospice and palliative care [...]
EssilorLuxottica: EssilorLuxottica Nomination and Compensation Committee initiates the search of a future Chief Executive Officer with the support of two international executive search firms
17/04/2019
EssilorLuxottica Nomination and Compensation Committee initiates the search of a future Chief Executive Officer with the support of two international executive search firms Charenton-le-Pont, France (April 17, 2019) - [...]

Pages